Acurx Pharmaceuticals (ACXP) EBIT (2024 - 2026)
Acurx Pharmaceuticals' (ACXP) quarterly EBIT came in at -$1.7 million in Q1 2026, up 21.16% YoY from -$1.4 million in Q1 2025, and down 6.11% on a QoQ basis from -$1.6 million in Q4 2025.
Acurx Pharmaceuticals (ACXP) EBIT (2024 - 2026) Analysis & Trends
Acurx Pharmaceuticals (ACXP) has 3 years of EBIT data on file, last reported at -$1.7 million in Q1 2026.
- Quarterly EBIT rose 21.16% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.6 million (up 35.97% YoY) and the FY2025 annual result came in at -$8.1 million, up 42.7% from the prior year.
- EBIT declined to -$1.7 million in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$1.6 million in Q4 2025 to a low of -$4.1 million in Q2 2024.
- A 3-year average of -$2.4 million and a median of -$2.2 million in 2025 frame the typical range for EBIT.
- Annual changes were most pronounced in 2025 — EBIT surged 44.95% — and 2026, when it gained 21.16%.
- Tracing ACXP's EBIT over 3 years: stood at -$2.8 million in 2024, then surged by 42.12% to -$1.6 million in 2025, then slipped by 6.11% to -$1.7 million in 2026.
- The last three EBIT figures came in at -$1.7 million (Q1 2026), -$1.6 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Acurx Pharmaceuticals | 6.18 Mn | 6.18 Mn | - | -2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.31 Mn |
| Mar 31, 2026 | -1.72 Mn |
| Dec 31, 2025 | -1.62 Mn |
| Sep 30, 2025 | -2.03 Mn |
| Jun 30, 2025 | -2.27 Mn |
| Mar 31, 2025 | -2.18 Mn |
| Dec 31, 2024 | -2.79 Mn |
| Sep 30, 2024 | -2.83 Mn |
| Jun 30, 2024 | -4.12 Mn |